WEZENLA 130 mg concentrate for solution for infusion | medicines.ie

Company: Amgen Ireland Ltd
Active Ingredient: Ustekinumab
Strength: Ustekinumab: 130 mg
Dosage Form: Solution for infusion
Legal Category: A - prescription, may not be renewed
Last Updated: 25/09/2026

Licence numbers with strength, ATC code and dosage form
Licence number	Strength	ATC Code	Dosage Form
EU/1/24/1823/004	130 mg	L04AC05	Solution for infusion

Licence number: EU/1/24/1823/004
Strength: 130 mg
ATC Code: L04AC05
Dosage Form: Solution for infusion

Amgen Ireland Ltd

21 Northwood Court, Santry, Dublin D09 TX31, Ireland 216 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire, CB4 0WA, UK

Website: https://www.amgen.co.uk
Telephone: +441223436441
Email: gbinfoline@amgen.com